Fujifilm Medical Systems USA has received FDA clearance for Synapse 3D, the latest addition to medical informatics product line, for sale in the US.
Synapse 3D is a suite of clinical applications that is integrated directly into both Synapse PACS and Synapse Cardiovascular, providing access to advanced diagnostic tools without the need for separate workstations.
Fujifilm said that Synapse 3D can be used with virtually any advanced imaging system, such as PET, CT, MR and nuclear medicine.
Synapse 3D is enterprise capable, as it is integrated directly into Synapse PACS and Synapse Cardiovascular, and is available at any workstation where Synapse PACS is available, including at home or from remote locations.
Synapse 3D automatically imports the advanced analysis back into the Synapse PACS and CVIS systems, creating one common information database and image storage location, the company said.
Fujifilm Medical Informatics vice president Jim Morgan said that to assure success in the advanced visualization market, Fujifilm made it a priority to gather extensive input from radiologists, cardiologists and surgeons when developing Synapse 3D.
"Fujifilm has integrated Synapse 3D directly into PACS and CVIS to improve workflow and accessibility, and we’ve drawn on our proven strengths in image processing and analysis to deliver superior clinical results," Morgan said.